Comparison of approximate intermolecular potentials for ab initio fragment calculations on medium sized N-heterocycles

Autor: Bónis Barcza, Ádám B. Szirmai, Katalin J. Szántó, Attila Tajti, Péter G. Szalay

The ground state intermolecular potential of bimolecular complexes of N-heterocycles is analyzed for the impact of individual terms in the interaction energy as provided by various, conceptually different theories. Novel combinations with several for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1755abf597522dc326a1c305e401f9a6
https://doi.org/10.26434/chemrxiv-2021-gv8xk-v2

P352 Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn’s disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study

Autor: P Bacsur, T Resál, P Miheller, T Szamosi, E Schäfer, P Sarlós, Á Iliás, K J Szántó, M Rutka, A Bálint, A Fábián, R Bor, S Zoltán, M Matuz, T Molnár, K Farkas

Publikováno v: Journal of Crohn's and Colitis. 16:i364-i364

Background Anti-tumor necrosis factor alpha treatments are effective and safe as first line therapy, however, their long-term efficacy is limited by primary (PNR) and secondary non-response (LOR) resulting in treatment discontinuation in approximatel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b20ad7540da3bdfc50705e8c3e7820f5
https://doi.org/10.1093/ecco-jcc/jjab232.479

Contents, Vol. 48,1991

Autor: G. Cattaneo, Yoshiya Katsura, Fabrizio Franchi, Takashi Yoshida, Ilona Péter, Hideaki Mizoguchi, Shuji Hashimoto, Reinhard Becher, Isao Sekiguchi, Klea Katsouyanni, Toshiteru Ohshima, Richard C. Moon, Jonathan S.T. Sham, Noriyuki Tatsumi, Herbert Höfeler, Peter Boyle, Ikuro Kimura, Ewan Cameron, S. Eckhardt, Tokujiro Yano, Sumiaki Tsuru, Diana Giannarelli, Masami Hirano, Kiyoshi Takatsuki, Arun B. Barua, Nina Konovalova, Rajendra G. Mehta, Nobuyuki Hara, B.P. Barna, Tohru Nakamura, Rudolf Richter, F. Fraschini, Patrizia Seminara, L.C. Chan, James A. Olson, Hiroshi Asoh, Nariyoshi Shinomiya, Masayuki Kawasaki, János Szántó, S.L. Loke, M.J. Thomassen, G. Esposti, Ryuzo Ohno, D. Esposti, Kuniyuki Imai, Dieter May, Jun Minowada, Masayuki Gotoh, G. Tancini, Kikuo Nomoto, Takeshi Otani, Otto Kloke, J. Sergi, Mitsuaki Suzuki, Tomoharu Kuda, Keisuke Toyama, S. Barni, Kazumasa Yamada, Yukito Ichinose, Max E. Scheulen, D. Choy, R.M. Bukowski, J. Szántó, Carl G. Schmidt, Thomas Jack, Yoshinobu Matsuo, Norbert Niederle, Kornél Daubner, Masayuki Noritake, Kiyoji Kimura, Masaaki Kosaka, Allan Campbell, P. Lissoni, S. Murthy, Taro Tamada, Dimitrios Trichopoulos, Tohru Masaoka, T. Fleischmann, Pratima Sur, Mitsuo Ohta, U. B. Wandl, Gábor Ringwald, Toshihiko Yamaya, György Liszka, Zsigmond Karika

Publikováno v: Oncology. 48:I-VI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c667d743bb097c6ad1eee2477bff5304
https://doi.org/10.1159/000226976

[The role of irinotecan in the treatment of advanced colorectal cancer]

Autor: L, Marázi, J, Szántó, J, Szota

Publikováno v: Magyar onkologia. 45(5)

PURPOSE: The purpose of the study was the evaluation of efficacy and the side effects of irinotecan in treatment of advanced colorectal cancer. METHODS: The authors presented their experiences with irinotecan in the treatment of 10 patients suffering

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ccf1cceceffae326c55a3ac758acdab4
https://pubmed.ncbi.nlm.nih.gov/12050687

[Irinotecan--experience with second-line treatment in advanced colorectal cancer]

Autor: K, Kristó, J, Izsó, G, Balatoni, J, Lohinszky, E, Farczádi, J, Szántó, A P, Kofi, T, Pintér

Publikováno v: Orvosi hetilap. 141(33)

The prognosis for patients with advanced colorectal cancer who fail to respond to a 5-FU based therapy is poor. About 7% response rate can be achieved with second line therapeutic regiments, the overall survival is about 6-7 months. The aim of author

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::542dfca7b345d6cc815cd2ec5617105f
https://pubmed.ncbi.nlm.nih.gov/10979311